IM

Ian Moore

Mr Moore has 40 years of experience in the international pharmaceutical industry, including almost 30 years as President of Novo Nordisk Japan.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
30/06/24N/A975,824N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
24/11/22
Issued
58,824$0.850$50,000Placement
24/10/22
Exercise
100,000$0.670$67,000Exercise of options
24/10/22
Issued
100,000$0.670$67,000Exercise of options
04/11/21
Issued
100,000$0.500$50,000Exercise of options
04/11/21
Exercise
100,000$0.500$50,000Exercise of options